Q2 FY2026 · ended Jun 30, 2026 · Revenue $336,000, -56.8% YoY · Filed Aug 14, 2026
Bio Green Med Solution, Inc. (BGMS) files with the SEC under industry code 5099, Wholesale-Durable Goods, NEC. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $336,000 and a net loss of $405,000. Free cash flow was -$352,000.
Revenue
$336,000
-56.8% vs prior quarter
Net income
$-405,000
+69.3% vs year-ago quarter
Operating cash flow
$-352,000
+66.7% vs year-ago quarter
Free cash flow
$-352,000
-26.2% vs prior quarter
EPS
$-2.21
-68.8% vs prior quarter
Dividend per share
None
Shares outstanding
6.62M
+195.8% vs year-ago quarter
Net cash
$3.48M
Q4 FY2025
Operating margin
-198.5%
TTM
Company profile
- Industry
- Wholesale-Durable Goods, NEC (SIC 5099)
- Listed as
- BGMS (Nasdaq), BGMSP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Berkeley Heights, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1130166
- Former names
- Cyclacel Pharmaceuticals, Inc. (until Sep 12, 2025); XCYTE THERAPIES INC (until Mar 24, 2006)
Other Wholesale-Durable Goods, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $336,000 | $778,000 | $666,000 | $81,000 | — |
| Operating income | -$418,000 | -$246,000 | -$1.1M | -$992,000 | -$1.2M |
| Net income | -$405,000 | -$197,000 | -$611,000 | -$988,000 | -$1.3M |
| Diluted EPS | — | — | -$2.21 | -$1.31 | -$0.98 |
| Operating cash flow | -$352,000 | -$278,000 | -$33,000 | -$434,000 | -$1.1M |
| Free cash flow | -$352,000 | -$279,000 | — | — | — |
| Total assets | $7.9M | $7.6M | $8.2M | $8.2M | $4.4M |
| Total liabilities | $694,000 | $804,000 | $1.3M | $1.1M | $770,000 |
| Stockholders' equity | $7.2M | $6.8M | $6.8M | $7.1M | $3.6M |
| Cash and investments | $3.8M | $3.3M | $3.5M | $3.8M | $4.3M |
| Total debt | — | — | $20,000 | $5,000 | $10,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Nov 4, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 16, 2026 | Oct 16, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
All 1000 Bio Green Med Solution, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.